SHL Telemedicine Crecimiento futuro

Future controles de criterios 4/6

Se prevé un crecimiento anual de los beneficios y los ingresos de SHL Telemedicine de 96.2% y 13.8%, respectivamente.

Información clave

96.2%

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	23.1%
Tasa de crecimiento de los ingresos	13.8%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	14 Mar 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

SHL Telemedicine Ltd. (VTX:SHLTN) Not Lagging Industry On Growth Or Pricing

Apr 20

We Think SHL Telemedicine Ltd.'s (VTX:SHLTN) CEO Compensation Package Needs To Be Put Under A Microscope

Dec 01

Is SHL Telemedicine (VTX:SHLTN) A Risky Investment?

Oct 28

Is SHL Telemedicine (VTX:SHLTN) Using Debt In A Risky Way?

Jun 23

SHL Telemedicine Ltd.'s (VTX:SHLTN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Mar 05

Are SHL Telemedicine's (VTX:SHLTN) Statutory Earnings A Good Guide To Its Underlying Profitability?

Feb 12

What Percentage Of SHL Telemedicine Ltd. (VTX:SHLTN) Shares Do Insiders Own?

Jan 21

Investors Who Bought SHL Telemedicine (VTX:SHLTN) Shares A Year Ago Are Now Up 120%

Jan 04

What Do The Returns At SHL Telemedicine (VTX:SHLTN) Mean Going Forward?

Dec 01

Previsiones de crecimiento de beneficios e ingresos

SWX:SHLTN - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2025	75	0	N/A	N/A	1
12/31/2024	62	-4	N/A	N/A	1
12/31/2023	57	-7	-7	-1	N/A
9/30/2023	57	-5	-9	-3	N/A
6/30/2023	57	-2	-12	-5	N/A
3/31/2023	58	-1	-9	-3	N/A
12/31/2022	59	0	-7	0	N/A
9/30/2022	59	-2	-5	1	N/A
6/30/2022	59	-4	-3	3	N/A
3/31/2022	55	-9	-3	1	N/A
12/31/2021	50	-14	-3	0	N/A
9/30/2021	46	-12	-2	1	N/A
6/30/2021	42	-10	0	2	N/A
3/31/2021	41	-5	1	3	N/A
12/31/2020	40	0	3	5	N/A
9/30/2020	40	1	4	6	N/A
6/30/2020	40	2	5	7	N/A
3/31/2020	41	4	7	9	N/A
12/31/2019	42	6	9	11	N/A
9/30/2019	42	6	13	14	N/A
6/30/2019	42	5	16	18	N/A
3/31/2019	45	8	14	15	N/A
12/31/2018	49	10	12	13	N/A
9/30/2018	49	10	5	7	N/A
6/30/2018	48	9	-1	1	N/A
3/31/2018	43	6	5	7	N/A
12/31/2017	37	2	10	12	N/A
9/30/2017	37	-1	N/A	12	N/A
6/30/2017	36	-5	N/A	12	N/A
3/31/2017	36	-8	N/A	6	N/A
12/31/2016	36	-11	N/A	0	N/A
9/30/2016	36	-15	N/A	-1	N/A
6/30/2016	36	-20	N/A	-1	N/A
3/31/2016	39	-19	N/A	4	N/A
12/31/2015	39	-16	N/A	4	N/A
9/30/2015	40	-8	N/A	4	N/A
6/30/2015	40	1	N/A	5	N/A
3/31/2015	39	2	N/A	-1	N/A
12/31/2014	40	1	N/A	-3	N/A
9/30/2014	39	4	N/A	-3	N/A
6/30/2014	36	3	N/A	-4	N/A
3/31/2014	33	3	N/A	-3	N/A
12/31/2013	30	2	N/A	3	N/A
9/30/2013	29	-5	N/A	2	N/A
6/30/2013	28	-5	N/A	2	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que SHLTN sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (0.1%).

Beneficios vs. Mercado: Se prevé que SHLTN sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: Se espera que SHLTN sea rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (13.8% al año) de SHLTN crezcan más rápidamente que los del mercado Swiss (4.2% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 13.8% al año) de SHLTN crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de SHLTN se prevé que sea elevada dentro de 3 años.

SHL Telemedicine Crecimiento futuro

Future controles de criterios 4/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Forecast to breakeven in 2025

Recent updates

SHL Telemedicine Ltd. to Report First Half, 2024 Results on Sep 26, 2024

SHL Telemedicine Ltd. (VTX:SHLTN) Not Lagging Industry On Growth Or Pricing

Full year 2023 earnings released: US$0.43 loss per share (vs US$0.005 loss in FY 2022)

Forecast to breakeven in 2025

SHL Telemedicine Ltd. Announces Full Results of the Imperial College London Tele-ACS Trial

SHL Telemedicine's SmartHeart Technology Triumphs in US Army Project Convergence - Capstone 4 Experiment

New minor risk - Financial data availability

SHL Telemedicine Ltd. Announces Erez Nachtomy, to Steps Down as CEO in Mid-June 2024

Value Base Ltd Provides Information to Shareholders of SHL Telemedicine

New minor risk - Market cap size

Insufficient new directors

SHL Telemedicine Ltd. Announces Board Changes

SHL Telemedicine Ltd. Announces Board Changes

SHL Telemedicine Ltd. to Report Fiscal Year 2023 Results on Apr 17, 2024

SHL Telemedicine Ltd., Annual General Meeting, Feb 08, 2024

Danbar Finance Nominates a Candidate to the Board of SHL Telemedicine

We Think SHL Telemedicine Ltd.'s (VTX:SHLTN) CEO Compensation Package Needs To Be Put Under A Microscope

Is SHL Telemedicine (VTX:SHLTN) A Risky Investment?

Shl Telemedicine Ltd. Announces the Initial Results from the Mayo Clinic Help-Mi and the Imperial College London Tele-Acs Trials

First half 2023 earnings released: US$0.14 loss per share (vs US$0.002 profit in 1H 2022)

Is SHL Telemedicine (VTX:SHLTN) Using Debt In A Risky Way?

Full year 2022 earnings released

SHL Telemedicine Ltd., Annual General Meeting, Dec 07, 2023

Less than half of directors are independent

SHL Telemedicine Ltd. Appoints Kimberly J. Henderson and Joshua H. Atkins to its US Advisory Board

SHL Telemedicine Ltd. Appoints Ehud Barak as Co-Chairman

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues miss analyst expectations

SHL Telemedicine Ltd. to Report Fiscal Year 2021 Results on Apr 14, 2022

SHL Telemedicine Ltd. to Report First Half, 2022 Results on Sep 22, 2022

First half 2021 earnings released: US$0.75 loss per share (vs US$0.01 profit in 1H 2020)

SHL Telemedicine Ltd completed the acquisition of a 70% stake in Mediton Medical Centers Ltd.

SHL Telemedicine Ltd. (SWX:SHLTN) signed an agreement to acquire 70% of the Mediton Group companies for ILS 84 million ($26 million).

Full year 2020 earnings released: EPS US$0.03 (vs US$0.54 in FY 2019)

SHL Telemedicine Ltd.'s (VTX:SHLTN) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

SHL Telemedicine Announces Executive Changes

Are SHL Telemedicine's (VTX:SHLTN) Statutory Earnings A Good Guide To Its Underlying Profitability?

What Percentage Of SHL Telemedicine Ltd. (VTX:SHLTN) Shares Do Insiders Own?

SHL Telemedicine Ltd. Files Pre-Submission with FDA for over the Counter Clearance of SHL’S Smartheart™ Full 12 Lead ECG

Investors Who Bought SHL Telemedicine (VTX:SHLTN) Shares A Year Ago Are Now Up 120%

New 90-day high: CHF10.90

Investor sentiment improved over the past week

What Do The Returns At SHL Telemedicine (VTX:SHLTN) Mean Going Forward?

New 90-day high: CHF8.80

SHL Telemedicine to Launch Doctors’ Virtual Visits with Health Insurance Company BARMER

AI Tool Jointly Develops by Hadassah Medical Center – SHL Telemedicine – Hebrew University

Market bids up stock over the past week

New 90-day high: CHF6.80

Market bids up stock over the past week

Mayo Clinic Collaborates with SHL Telemedicine using SmartHeart™ Technology 12 lead ECG

New 90-day high: CHF5.90

First half earnings released

New 90-day low - CHF5.30

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento